- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for per
GUTS Stock Earnings: Fractyl Health Beats EPS for Q1 2024
GUTS stock results show that Fractyl Health beat analyst estimates for earnings per share the first quarter of 2024.
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024
UNCY stock results show that Unicycive Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
APRE Stock Earnings: Aprea Therapeutics Beats EPS for Q1 2024
APRE stock results show that Aprea Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
MAG Stock Earnings: MAG Silver Beats EPS for Q1 2024
MAG stock results show that MAG Silver beat analyst estimates for earnings per share the first quarter of 2024.
CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2024
CYCC stock results show that Cyclacel Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
TCON Stock Earnings: TRACON Pharma Misses EPS for Q1 2024
TCON stock results show that TRACON Pharma missed analyst estimates for earnings per share the first quarter of 2024.
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q1 2024
BIOR stock results show that Biora Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
SCWO Stock Earnings: 374Water Meets EPS for Q1 2024
SCWO stock results show that 374Water met analyst estimates for earnings per share the first quarter of 2024.
NTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024
NTBL stock results show that Notable Labs missed analyst estimates for earnings per share the first quarter of 2024.
CKPT Stock Earnings: Checkpoint Therapeutics Misses EPS for Q1 2024
CKPT stock results show that Checkpoint Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024
ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
TIL Stock Earnings: Instil Bio Misses EPS for Q1 2024
TIL stock results show that Instil Bio missed analyst estimates for earnings per share the first quarter of 2024.
PROK Stock Earnings: ProKidney Beats EPS for Q1 2024
PROK stock results show that ProKidney beat analyst estimates for earnings per share the first quarter of 2024.
AKRO Stock Earnings: Akero Therapeutics Beats EPS for Q1 2024
AKRO stock results show that Akero Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
KPRX Stock Earnings: Kiora Pharmaceuticals Beats EPS for Q1 2024
KPRX stock results show that Kiora Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024.
ENTX Stock Earnings: Entera Bio Beats EPS for Q1 2024
ENTX stock results show that Entera Bio beat analyst estimates for earnings per share the first quarter of 2024.
SAVA Stock Earnings: Cassava Sciences Beats EPS for Q1 2024
SAVA stock results show that Cassava Sciences beat analyst estimates for earnings per share the first quarter of 2024.
EDSA Stock Earnings: Edesa Biotech Beats EPS for Q2 2024
EDSA stock results show that Edesa Biotech beat analyst estimates for earnings per share the second quarter of 2024.
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q1 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the first quarter of 2024.
REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
REVB stock results show that Revelation Biosciences missed analyst estimates for earnings per share the first quarter of 2024.
GOVX Stock Earnings: Geovax Labs Beats EPS for Q1 2024
GOVX stock results show that Geovax Labs beat analyst estimates for earnings per share the first quarter of 2024.
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024
MAIA stock results show that MAIA Biotechnology missed analyst estimates for earnings per share the first quarter of 2024.
ACXP Stock Earnings: Acurx Pharmaceuticals Misses EPS for Q1 2024
ACXP stock results show that Acurx Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.
HOTH Stock Earnings: Hoth Therapeutics Misses EPS for Q1 2024
HOTH stock results show that Hoth Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
2 – 10 of 240 results
